DDIT3 and diffuse large B-cell lymphoma: In HBsAg-positive DLBCL group (Table 2), there was a strong trend that the response in the R-CHOP group was better than that in the CHOP group with a higher rate of complete response (57.6% vs 22.9%, p = 0.051).